Becton, Dickinson and Company (BD) develops, manufactures, and sells a wide range of medical supplies, devices, and diagnostic products primarily for healthcare institutions and laboratories. The company operates through three main segments: BD Medical, which contributes approximately 50% of revenue, BD Life Sciences at about 30%, and BD Interventional at around 20%. Revenue is generated from products such as IV catheters, blood collection systems, and surgical instruments. Factors supporting BD's endurance include a strong demand for healthcare products and a long history in the industry, while potential limitations may arise from regulatory challenges and competition in the medical device market.
—
Becton, Dickinson and Company (BD) develops, manufactures, and sells a wide range of medical supplies, devices, and diagnostic products primarily for healthcare institutions and laboratories. The company operates through three main segments: BD Medical, which contributes approximately 50% of revenue, BD Life Sciences at about 30%, and BD Interventional at around 20%. Revenue is generated from products such as IV catheters, blood collection systems, and surgical instruments. Factors supporting BD's endurance include a strong demand for healthcare products and a long history in the industry, while potential limitations may arise from regulatory challenges and competition in the medical device market.
—
Daily adjusted close
Becton, Dickinson and Company (BD) develops, manufactures, and sells a wide range of medical supplies, devices, and diagnostic products primarily for healthcare institutions and laboratories. The company operates through three main segments: BD Medical, which contributes approximately 50% of revenue, BD Life Sciences at about 30%, and BD Interventional at around 20%. Revenue is generated from products such as IV catheters, blood collection systems, and surgical instruments. Factors supporting BD's endurance include a strong demand for healthcare products and a long history in the industry, while potential limitations may arise from regulatory challenges and competition in the medical device market.